These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Acidity and intestinal bacteria: an in-vitro assessment of the bactericidal activity of hydrochloric acid on intestinal pathogens. Rotimi VO; Egwari L; Akande B Afr J Med Med Sci; 1990 Dec; 19(4):275-80. PubMed ID: 2127996 [TBL] [Abstract][Full Text] [Related]
33. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment. Sparo MD; Jones DG; Sánchez Bruni SF Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489 [TBL] [Abstract][Full Text] [Related]
34. Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus. Ferrara AM Int J Antimicrob Agents; 2007 Jul; 30(1):19-24. PubMed ID: 17475449 [TBL] [Abstract][Full Text] [Related]
35. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). Sader HS; Watters AA; Fritsche TR; Jones RN BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104 [TBL] [Abstract][Full Text] [Related]
36. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. Otter JA; Cummins M; Ahmad F; van Tonder C; Drabu YJ J Hosp Infect; 2007 Oct; 67(2):182-8. PubMed ID: 17884250 [TBL] [Abstract][Full Text] [Related]
37. Two studies feed the debate on active surveillance for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci carriage: to screen or not to screen? Talbot TR J Infect Dis; 2007 Feb; 195(3):314-7. PubMed ID: 17205467 [No Abstract] [Full Text] [Related]
38. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Martins SA; Combs JC; Noguera G; Camacho W; Wittmann P; Walther R; Cano M; Dick J; Behrens A Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3402-8. PubMed ID: 18408193 [TBL] [Abstract][Full Text] [Related]
39. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Appelbaum PC Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634 [TBL] [Abstract][Full Text] [Related]
40. Variability of adenosine triphosphate-based bioluminescence assay readings among drug-resistant pathogens. Heller M; Thompson PA; Loock MH; Sawchuk A; Guerrero DM Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1286-8. PubMed ID: 23143378 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]